Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Integra Lifesciences Holdings (IART) Long-Term Debt Issuances (2016 - 2025)

Historic Long-Term Debt Issuances for Integra Lifesciences Holdings (IART) over the last 14 years, with Q3 2025 value amounting to $603.7 million.

  • Integra Lifesciences Holdings' Long-Term Debt Issuances rose 266926.61% to $603.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $706.4 million, marking a year-over-year increase of 5052.21%. This contributed to the annual value of $486.5 million for FY2024, which is 19466.99% up from last year.
  • According to the latest figures from Q3 2025, Integra Lifesciences Holdings' Long-Term Debt Issuances is $603.7 million, which was up 266926.61% from $12.9 million recorded in Q2 2025.
  • Integra Lifesciences Holdings' Long-Term Debt Issuances' 5-year high stood at $603.7 million during Q3 2025, with a 5-year trough of $600000.0 in Q1 2021.
  • In the last 5 years, Integra Lifesciences Holdings' Long-Term Debt Issuances had a median value of $12.0 million in 2021 and averaged $73.1 million.
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first plummeted by 9989.57% in 2021, then surged by 353235.29% in 2024.
  • Integra Lifesciences Holdings' Long-Term Debt Issuances (Quarter) stood at $12.0 million in 2021, then tumbled by 46.06% to $6.5 million in 2022, then soared by 180.0% to $18.2 million in 2023, then skyrocketed by 94.51% to $35.4 million in 2024, then soared by 1605.37% to $603.7 million in 2025.
  • Its Long-Term Debt Issuances stands at $603.7 million for Q3 2025, versus $12.9 million for Q2 2025 and $54.4 million for Q1 2025.